VSL3 Medical Grade Probiotic was found in early 1990's by Italian professor Claudio De Simone. Originally intended for the dietary management of ulcerative colitis, irritable bowel syndrome and an ileal pouch. De Simone Formulation became known as VSL3 Medical Grade Probiotic. For many years this formulation has helped patients to battle unpleasant symptoms and getting them under control. VSL3 formulation is over 20 years old and with over 60 clinical studies VSL3 formulation is the most studied in the world. As sellers of VSL3 we get a lot of positive feedbacks from our customers.
VSL3 Medical Grade Probiotic.
For many years manufactured in Italy, VSL3 contained Dairy Free Formulation. However, in the later time VSL3 production was moved to USA and became Non Dairy Free. Produced in capsule and powder form, VSL3 Medical Grade Probiotic formulation contains one of the largest amount of live bacteria available in any other probiotic formulation. VSL 3 capsule contains 112.5 Billion Bacteria per capsule, while VSL3 Powder Packet contains 450 Billion Bacteria. VSL3 capsules come in a bottle of 60's. The Powder Packets of VSL3 are availble in a count of 30's. Original Flavored and Unflavored powder form went alteration after VSL3 production mowed back to Italy. This alteration also allowed VSL3 to convert back to its original Dairy Free formulation. However, the Flavored powder form of VSL3 is not available at this time.
VSL3 Medical Grade Probiotic.
VSL3 formulation contains 8 steins of live bacteria. This bacteria is naturally produced in our body and beneficial for our digestive as well as immune systems. As a part of the good diet, VSL3 can effectively reduce or compliantly eliminate symptoms of IBD, UC as well as other digestive deceases.
VSL3 is available over the counter. However, VSL3 is a High Potency Medical Food and requires supervision of a physician. VSL3 is also available in a prescription strength. VSL3 DS comes in a count of 20 and requires a prescription.
Formulation of VSL3 is available at Vitamin Cove USA.
No comments:
Post a Comment